Literature DB >> 11558698

Perspectives on the pharmaceutical industry.

U E Reinhardt1.   

Abstract

This paper seeks to provide an economic perspective on the pharmaceutical industry, which has come under increasing criticism on a number of issues. In the main, that criticism amounts to a rather ineffective flailing at the supply side of the market for pharmaceutical products-much of it based on inaccurate perceptions-when a more productive policy would be to strengthen the hitherto weak and poorly informed demand side of the market.

Mesh:

Year:  2001        PMID: 11558698     DOI: 10.1377/hlthaff.20.5.136

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  BiDil: assessing a race-based pharmaceutical.

Authors:  Howard Brody; Linda M Hunt
Journal:  Ann Fam Med       Date:  2006 Nov-Dec       Impact factor: 5.166

2.  Proceeding in a receding economy.

Authors:  George A Scangos
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

3.  Bridging the Valley of Death of therapeutics for neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

4.  The other ex ante moral hazard in health.

Authors:  Jay Bhattacharya; Mikko Packalen
Journal:  J Health Econ       Date:  2011-09-16       Impact factor: 3.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.